Abstract A135: GS24-B057, a potential best-in-class Nectin-4- and Trop-2-directed bispecific ADC, for the treatment of multiple solid tumors

作者
M Y Li,Li Fu,Qiuru Che,Dongxia Chu,Qiyang Zhang,Xiaojing Huang,Nan Li,Qingjuan Ma,Shaonan Liang,Wei‐Ming He,Yi-Hui Lin,Wen-qiang Zhai,Fanglong Yang,Siqing Wang,Lei Jin,Shicheng Xu
出处
期刊:Molecular Cancer Therapeutics [American Association for Cancer Research]
卷期号:24 (10_Supplement): A135-A135
标识
DOI:10.1158/1535-7163.targ-25-a135
摘要

Abstract Background: Nectin-4 and Trop-2 are transmembrane proteins commonly co-overexpressed in various solid tumors and associated with tumor progression. ADCs targeting Nectin-4 or Trop-2 have shown promising therapeutic potential in urothelial carcinoma (UC), non-small cell lung cancer (NSCLC), and triple-negative breast cancer (TNBC). Notably, the combination of Padcev™ (a Nectin-4-directed ADC; also referred to as EV) and Trodelvy™ (a Trop-2-directed ADC; also referred to as SG) as second-line therapy for metastatic UC has demonstrated significantly improved efficacy, with the overall response rate (ORR) reaching 70%. However, the safety profile of this combination remains to be a concern, with ≥Grade 3 treatment-emergent adverse events (TEAEs) occurring in 78% of patients. To enhance clinical efficacy while minimizing toxicity, we developed GS24-B057, a dual Nectin-4- and Trop-2-targeting ADC with a drug-to-antibody ration (DAR) of 6, integrating an optimally engineered bispecific antibody, a tailored topoisomerase I inhibitor payload, and site-specific conjugation. Materials and Methods: The in vitro tumor cell binding and internalization activity of GS24-B057 were evaluated by flow cytometry in Nectin-4 and Trop-2 positive cell lines. Cytotoxicity and bystander killing effect were assessed in a Cell Titer-Glo assay and in a luciferase assay, respectively. The in vivo anti-tumor efficacy of GS24-B057 was systematically examined in a number of human cancer cell line-derived xenograft (CDX) models in mice. Results: In preclinical studies, GS24-B057 exhibited significantly stronger in vitro cell binding and internalization than EV and SG, as well as robust direct cytotoxicity and pronounced bystander killing effect in tumor cell lines. GS24-B057 demonstrated superior in vivo anti-tumor efficacy as compared to the EV and SG combination in a number of CDX models including UC and TNBC. A pilot non-GLP 4-week repeat dose toxicity study in cynomolgus monkeys has been planned. Conclusion: These data suggest the potential of GS24-B057 as an effective therapeutic option for patients with UC and TNBC and support its further evaluation in IND-enabling studies. Citation Format: Meihan Li, Fu Li, Qiuru Che, Dongxia Chu, Qiyang Zhang, Xiaojing Huang, Nan Li, Qingjuan Ma, Shaonan Liang, Weiming He, Yihui Lin, Wenqiang Zhai, Fanglong Yang, Siqing Wang, Lei Jin, John L. Xu. GS24-B057, a potential best-in-class Nectin-4- and Trop-2-directed bispecific ADC, for the treatment of multiple solid tumors [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; 2025 Oct 22-26; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2025;24(10 Suppl):Abstract nr A135.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
莓莓发布了新的文献求助10
刚刚
陈杰77完成签到,获得积分20
1秒前
在水一方的应助被Suifqh采纳,获得10
1秒前
研友_8Y2DXL完成签到,获得积分10
2秒前
sun完成签到,获得积分10
2秒前
老实人sdu发布了新的文献求助10
2秒前
羲成完成签到,获得积分10
4秒前
慕青的应助被哈哈哈采纳,获得10
4秒前
4秒前
小二郎的应助被moriaty采纳,获得10
6秒前
火星上的海亦完成签到,获得积分10
7秒前
我是老大的应助被洁净的千凡采纳,获得10
7秒前
小木没有烦恼完成签到 ,获得积分10
7秒前
理穆辛完成签到 ,获得积分10
7秒前
8秒前
外向夜春完成签到 ,获得积分10
9秒前
小艾同学发布了新的文献求助10
9秒前
Roux给Roux的求助进行了留言
10秒前
善良的采蓝的应助被土豪的城采纳,获得30
10秒前
hhh发布了新的文献求助10
12秒前
Davin_ji完成签到 ,获得积分10
12秒前
星辰大海的应助被wwwwwl采纳,获得10
13秒前
13秒前
14秒前
14秒前
15秒前
椰子鸡完成签到 ,获得积分10
15秒前
15秒前
15秒前
Charles完成签到,获得积分10
16秒前
16秒前
16秒前
fantasy的应助被隔岸采纳,获得10
16秒前
芽卉完成签到 ,获得积分10
17秒前
爆米花的应助被鼻毛好胜采纳,获得10
17秒前
乐乐的应助被111采纳,获得10
18秒前
WZJ发布了新的文献求助30
18秒前
chaoqi完成签到,获得积分10
19秒前
CipherSage的应助被Leonard采纳,获得10
19秒前
Danny完成签到,获得积分20
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181498
求助须知:如何正确求助?哪些是违规求助? 9571421
关于积分的说明 21817968
捐赠科研通 7777967
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479552